Motif Bio Share Discussion Threads

[kirk 6] 14/2/2019 11:24

Booooom 12p

[timw3] 14/2/2019 11:19

Oversold IMM dropped from 150p to 18p...over reaction

Then rose to 50p

Motif:

This one will go 150% from 5-6p LEVELS.

[timw3] 14/2/2019 11:17

buckle up chaps 120m traded all ready today.12p+ end of day

[ssrover] 14/2/2019 11:15

make no mistake the only reason it's hung around in the 5's is heavy II selling. But look at the insane volume - the overhang is getting smashed and once released it'll fly back to 10-15p no probs just based on market mechanics let alone the fact it's just a delay

[sunnybeachboy] 14/2/2019 11:11

Large sellers on the weigh scales pushed the price down to an unbelievable 5p.Picture the weigh scales once they are cleared its boom ....

[glenbo1] 14/2/2019 11:03

Bought loads just under 5p

[glenbo1] 14/2/2019 11:02

The fundraise will not happen in my opinion until a further release from the approval authorities. Ie the FDA.If it is tweaked and gets approval.the share price will be tenfold at least the current price.Just my opinion

[stansmith3] 14/2/2019 11:00

glenbohave you considered that the ceiling now on a successful approval could now be much lower?

[stansmith3] 14/2/2019 10:59

glenbowhat do you think the fundraise will be given that you can buy for 5p now?

[timbo003] 14/2/2019 10:54

Iclaprim an is antibiotic, so it is intended for short term use only, so surely they will not be asked to do longer term studies?


I am just speculating now, but I suspect they are seeing elevated liver enzymes in just a small portion of patients (with a certain genotype) and it is probably not easy to identify which patients will have this genotype prior to dosing.

If it takes a day or two (?) to do the genotyping, the infection will have gone untreated whilst waiting for test results which would be unacceptable, on the other hand, if there was a quick and easy point of care test to enable genotyping, then that wouldn't be such a big problem.

It will be 30 - 45 days to wait before we know more by the sounds of it.

[mike1608] 14/2/2019 10:44

glenbo1, you go buy some. I will cheer you from the sidelines

[bountyhunter] 14/2/2019 10:39

I agree Nick, also unfortunately we got hit twice by this morning's RNS, now it's all down to whether/when the requested liver toxicity data can be supplied. We should hear more on that in a month or so after the planned FDA meeting.

[vulgaris] 14/2/2019 10:39

Given that concerns re. liver tox comes up repeatedly in the EMEA rejection of a decade ago ( one might have hoped they'd pay particular attention to this aspect, yet it sounds to be the crux of the FDA's concerns.

[nick rubens] 14/2/2019 10:33

cheers bountyhunter

I often wonder how good these pharma claims generally really are. The company's raising money are always saying how great their invention is and then so often the FDA says something else.

I really would like to know exactly what the FDA said. Not much detail in the RNS IMO.

[glenbo1] 14/2/2019 10:27

2p fundraise what planet are you on for a drug that has passed every clinical trial stage..It says they cannot have approval in current format. Minor tweaks..My advice buy in now and don't wait for 2p.

[regandharry5] 14/2/2019 10:22

They have already announced that they will need to raise funds. Personally I think the fundraising will be at around 2p. Not a holder here. Bought into the dream at 28p and sold at 42p. Had been thinking of buying in again when it was aroud the 20p mark. Very glad i didnt.

[glenbo1] 14/2/2019 10:20

The company are gobsmacked they didn't get approval. All clinical trials went well.To me it's a bargain at 5p

[herb clark] 14/2/2019 10:18

5.4696 are buys!

[pretax2] 14/2/2019 10:16

I'm surprised this has flat lined.
Thought about taking a punt having had an investment here before, but decided it's too risky.
someone once said that the first piece of bad news is usually not the last. I sense that something's lurking, may be the fundraise.
Might pick up later.

[glenbo1] 14/2/2019 10:13

The meeting will be within weeks.Run out of cash tut tut...

[mike1608] 14/2/2019 10:10

if they get a meeting quickly and not run out of money, then maybe it might go back upto 10p.

[mike1608] 14/2/2019 10:09

"At 31 December 2018, the Company had cash of $12.3 million and $15 million of debt drawn from its Hercules loan facility. The Company is financed into the second quarter of 2019 but will need to raise capital in the near term. "

[mirabeau] 14/2/2019 09:51

I've been in this situation and for any newbies let me tell two things

1 - You never expose your capital to binary (win or lose) risk (ie drug approval decision, drill results etc etc)

2 - Learn from this and remember there's always, always another opportunity to recoup your losses.

good luck and don't become despondent...investing is all about learning from your mistakes and those mistakes are always expressed in monetary losses which can have devastating consequences...take control of your trading